Insights into the contemporary epidemiology and outpatient management of congestive heart failure

American Heart Journal

Volumn 138, Issue 1 I, 1999, Pages 87-94

  McAlister, F A ^a   Teo, K K ^a   Taher, M ^a   Montague, T J ^a   Humen, D ^a   Cheung, L ^a   Kiaii, M ^a   Yim, R ^a   Armstrong, P W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; LISINOPRIL; LOOP DIURETIC AGENT; METOLAZONE; POTASSIUM; THIAZIDE DIURETIC AGENT; WARFARIN;

ARTICLE; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MORTALITY; OUTPATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; SYSTOLE;

EID: 0032773173     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70251-6     Document Type: Article

References (44)

1. Yusuf S, Thom T, Abbot RD. Changes in hypertension and in congestive heart failure mortality. Hypertension 1989;13(Suppl I):I74-9.
2. Garg R, Packer M, Pitt B, Yusuf S. Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol 1993;22(Suppl A):3A-5A.
3. Eriksson H, Svardsudd K, Larsson B, et al. Quality of life in early heart failure: the study of men born in 1913. Scand J Prim Health Care 1988;6:161-7.
4. Rodeheffer RJ, Jacobsen SJ, Gersch BJ, et al. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 1993;68:1143-50.
5. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15.
6. Bourassa MG, Gurne O, Bangdiwala S, et al. for the SOLVD Investigators. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 1993;22(Suppl A):14A-19A.
7. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99-104.
8. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-5.
9. Bonneux L, Barendregt JJ, Meeter K, Bonsel GJ, van der Maas PJ. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Pub Health 1994;84:20-8.
10. Brophy JM. Epidemiology of congestive heart failure: Canadian data from 1970 to 1989. Can J Cardiol 1992;8:495-8.
11. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
12. Yusuf S, Held P, Teo KK. Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria. Stat Med 1990;9:73-86.
13. The Clinical Quality Improvement Network (CQIN) Investigators. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy. Arch Intern Med 1996;156:1669-73.
14. McDermott MM, Feinglass J, Sy J, Gheorghiade M. Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy. Am J Med 1995;99:629-35.
15. Young JB, Weiner DH, Yusuf S, et al. Patterns of medication use in patients with heart failure: a report from the registry of studies of left ventricular dysfunction (SOLVD). South Med J 1995;88:514-23.
16. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997;30:725-32.
17. Stevenson WG, Stevenson LW, Middlekauff HR, et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 1995;26:1417-23.
18. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
19. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
20. The DIG Investigators. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997;336:525-33.
21. Missouris CG, MacGregor GA. The use of angiotensin-converting enzyme inhibitors in the treatment of heart failure in hospital practice. Postgrad Med J 1997;73:409-11.
22. Chin MH, Wang JC, Zhang JX, Lang RM. Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. Effect of physician specialty and patient characteristics. J Gen Intern Med 1997;12:563-6.
23. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
24. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with isosorbide-dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
25. Riegger GAJ. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure. Eur Heart J 1991;12:705-11.
26. Pacher R, Globits S, Bergler-Klein J, et al. Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages. Eur Heart J 1993;14:273-8.
27. Vagelos R, Nejedly M, Wilson K, Yee YG, Fowler M. Comparison of low versus high dose enalapril therapy for patients with severe congestive heart failure [abstract]. J Am Coll Cardiol 1991;17:275A.
28. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Investigators. Preliminary result presented at the 1998 Annual Scientific Meeting, American College of cardiology.
29. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features, and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995;26:1565-74.
30. Madsen BK, Hansen JF, Stokholm KH, Brons J, Husum D, Mortensen LS. Chronic congestive heart failure: description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J 1994; 15:303-10.
31. Cohn JN, Johnson G. Heart failure with normal ejection fraction: the V-HeFT study. Circulation 1990;81(Suppl III):III 48-53.
32. Ghali JK, Kadakia S, Cooper RS, Liao Y. Bedside diagnosis of preserved versus impaired left ventricular systolic function in heart failure. Am J Cardiol 1991;67:1002-6.
33. Setaro JF, Soufer R, Remetz MS, et al. Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol 1992;69:1212-6.
34. Gaasch WH. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. JAMA 1994;271: 1276-80.
35. Andersson B, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J 1993; 126:632-40.
36. Matoba M, Matsui S, Hirakawa T, et al. Long-term prognosis of patients with congestive heart failure. Jpn Circ J 1990;54:57-61.
37. Rouleau J, Shenasa M, de Champlain J, Nadeau R. Predictors of survival and sudden death in patients with stable severe congestive heart failure due to ischemic and nonischemic causes: A prospective long term study of 200 patients. Can J Cardiol 1990;6:453-60.
38. Parameshwar J, Keegan J, Sparrow J, Sutton GC, Poole-Wilson PA. Predictors of prognosis in severe chronic heart failure. Am Heart J 1992;123:421-6.
39. Bart BA, Shaw LK, McCants CB, Fortin DF, Lee KL, O'Connor CM. Clinical determinants of mortality in patients with angiographically proven ischemic and non-ischemic cardiomyopathy [abstract]. Circulation 1996;94(Suppl I):I-193.
40. Saxon LA, Stevenson WG, Middlekauff HR, et al. Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1993;72:62-5.
41. Gradman AH, Deedwania PC. Predictors of mortality in patients with heart failure. Cardiol Clin 1994;12:25-35.
42. Dargie HJ, Cleland JGF, Leckie VJ, Inglis CG, East BW, Ford I. Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure. Circulation 1987;75:98-107.
43. Anguita M, Arizon JM, Bueno G, et al. Clinical and hemodynamic predictors of survival in patients age <65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1993;72:413-7.
44. Cohn J, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.